COVID Concerns Are Rising in China Again: Will This Send Moderna's Stock Soaring?
The number of people with COVID-19 has been rising rapidly in China in recent weeks, and there are concerns that the government in Beijing could consider reviving its strict lockdown policies again. A surge in COVID-19 there means other parts of the world could soon face similar problems. And if that happens, demand for COVID-19 vaccines such as 's (NASDAQ: MRNA) Spikevax could reaccelerate.
Does that mean that this would be an opportune time to buy shares of the biotech company? Let's take a look.
COVID-19 cases have been surging in China, largely due to the spread of the omicron XBB variants. Earlier this year, these variants became the most prevalent ones in the U.S. as well.
Source Fool.com
Moderna Inc. Stock
€128.00
0.310%
We see a rather positive sentiment for Moderna Inc. with 19 Buy predictions and 2 Sell predictions.
With a target price of 135 € there is a slightly positive potential of 5.47% for Moderna Inc. compared to the current price of 128.0 €.
